HeartBeam Stock (NASDAQ: BEAT) stock price, news, charts, stock research, profile.
You can purchase shares of HeartBeam (NASDAQ:BEAT) through any online brokerage.
Other companies in HeartBeam’s space includes: Precision Optics Corp (NASDAQ:POCI), LENSAR (NASDAQ:LNSR), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD) and Baird Medical Investment (NASDAQ:BDMD).
HeartBeam has a consensus price target of $6.78.
The stock price for HeartBeam (NASDAQ: BEAT) is $2.21 last updated December 20, 2024 at 7:49 AM EST.
There are no upcoming dividends for HeartBeam.
HeartBeam’s Q4 earnings are confirmed for Wednesday, March 19, 2025.
There is no upcoming split for HeartBeam.
HeartBeam is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.